Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125788881 | 12578888 | 1 | I | 20160708 | 20160721 | 20160721 | EXP | US-AUROBINDO-AUR-APL-2016-09512 | AUROBINDO | MANCANO MA.. HIGH-DOSE LOPERAMIDE ABUSE INDUCING LIFE-THREATENING CARDIAC ARRHYTHMIAS TOPIRAMATE-INDUCED DIARRHEA IN A BREASTFED INFANT DANAZOL-INDUCED STEVENS-JOHNSON SYNDROME ASENAPINE-INDUCED MYASTHENIC SYNDROME BLACK HAIRY TONGUE DUE TO LINEZOLID ADALIMUMAB-INDUCED PRIAPISM. ;. HOSPITAL PHARMACY. 2015;50(5):351-355 | 30.00 | YR | M | Y | 0.00000 | 20160721 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125788881 | 12578888 | 1 | PS | Loperamide | LOPERAMIDE | 1 | Unknown | 2 MG, (UPTO 200 OF 2 MG TABLETS(ABOUT 400 MG)) | U | 206548 | 2 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125788881 | 12578888 | 1 | Drug withdrawal syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125788881 | 12578888 | HO |
| 125788881 | 12578888 | LT |
| 125788881 | 12578888 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125788881 | 12578888 | Cardiac arrest | |
| 125788881 | 12578888 | Drug abuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |